data_1exg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1exg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.897 0.38 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t -90.55 56.6 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.797 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -161.93 -92.87 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.39 68.32 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.489 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.72 -155.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.866 1.711 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.487 ' H ' ' HB ' ' A' ' 105' ' ' THR . . . -87.03 -161.71 0.71 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.501 -0.879 . . . . 1.1899999999999999 111.007 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.99 45.65 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.877 -1.689 . . . . 0.54000000000000004 108.877 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.646 ' SG ' ' CD1' ' A' ' 102' ' ' LEU . 15.1 p -58.18 -168.25 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.04 -0.664 . . . . 0.68999999999999995 110.99 -179.991 53.509 61.982 -132.79 104.407 2.025 104.584 94.138 -152.118 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -152.29 137.76 17.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.927 -1.109 . . . . 2.1800000000000002 110.624 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 2.9 m -125.7 127.38 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.544 -0.862 . . . . 1.1699999999999999 111.249 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -98.42 164.95 12.07 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.134 -1.027 . . . . 1.0900000000000001 110.246 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.501 ' CE3' ' CB ' ' A' ' 96' ' ' ALA . 2.2 t-105 -120.54 146.23 46.52 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.954 -0.698 . . . . 0.54000000000000004 111.989 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.99 72.61 0.47 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.223 -1.951 . . . . 0.34000000000000002 108.223 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.11 150.65 10.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.573 -0.851 . . . . 1.3500000000000001 112.589 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -159.15 85.92 0.81 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.722 -1.126 . . . . 1.6200000000000001 109.151 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.806 ' H ' HE21 ' A' ' 16' ' ' GLN . 0.0 OUTLIER -108.21 164.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.648 -0.821 . . . . 2.8599999999999999 112.712 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -115.99 -83.24 0.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.012 -1.449 . . . . 1.6299999999999999 110.503 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.86 -24.59 16.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.476 -0.89 . . . . 3.7799999999999998 110.456 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.472 HG21 ' N ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -177.32 -35.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.567 -0.742 . . . . 2.2200000000000002 109.988 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.472 ' N ' HG21 ' A' ' 19' ' ' THR . . . -71.17 119.56 8.01 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 107.069 -2.412 . . . . 0.88 107.069 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 21' ' ' PHE . 28.1 p90 -113.74 119.11 36.25 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 119.602 -0.839 . . . . 2.1899999999999999 112.892 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -71.64 172.47 9.63 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.465 -1.309 . . . . 1.4299999999999999 107.465 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' CB ' ' CZ ' ' A' ' 86' ' ' PHE . . . -148.97 104.75 3.47 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.181 -1.408 . . . . 1.1200000000000001 112.176 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.1 102.26 15.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.429 -0.952 . . . . 2.0099999999999998 108.429 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.502 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 16.9 t -101.32 143.56 14.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.567 -0.853 . . . . 1.0900000000000001 112.545 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.471 ' N ' HG11 ' A' ' 25' ' ' VAL . 1.3 m -134.05 117.5 16.71 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.987 -1.006 . . . . 1.1299999999999999 109.135 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.25 152.77 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.319 -0.952 . . . . 1.1100000000000001 112.338 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' HD3' ' CG2' ' A' ' 81' ' ' THR . 13.8 tptt -139.51 104.72 5.01 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.85 -1.068 . . . . 2.5899999999999999 110.088 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.677 ' C ' HD21 ' A' ' 29' ' ' ASN . 0.2 OUTLIER -100.72 127.69 47.04 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.538 -0.865 . . . . 1.49 109.73 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.427 ' N ' HD21 ' A' ' 29' ' ' ASN . 2.4 t -134.13 10.23 3.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.47 -0.786 . . . . 1.3799999999999999 110.087 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -59.34 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.526 -0.87 . . . . 1.28 111.003 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 31' ' ' SER . 0.5 OUTLIER 162.61 42.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.051 -0.659 . . . . 1.2 111.181 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' H ' ' HB3' ' A' ' 78' ' ' ALA . . . -146.61 153.28 46.92 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 118.752 -1.179 . . . . 1.3799999999999999 111.306 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.05 100.98 0.9 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.519 1.48 . . . . 0.82999999999999996 110.395 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.6 t -78.48 98.69 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 118.606 -1.238 . . . . 1.1200000000000001 111.411 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -107.61 58.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.814 -0.81 . . . . 1.23 108.814 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.63 157.92 26.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.167 -1.973 . . . . 0.28000000000000003 108.167 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.782 ' NE1' ' ND2' ' A' ' 69' ' ' ASN . 41.3 p-90 -170.56 177.98 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.972 -1.491 . . . . 0.25 112.301 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.492 ' H ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -141.36 100.08 3.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.052 -0.976 . . . . 1.0700000000000001 110.641 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.605 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -87.1 173.23 9.39 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.48 -1.288 . . . . 1.1000000000000001 109.657 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.48 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.4 m -159.52 147.1 17.1 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.996 -1.482 . . . . 1.0700000000000001 112.404 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD2' ' N ' ' A' ' 43' ' ' SER . 18.8 p90 -174.22 -143.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.961 -1.472 . . . . 2.0600000000000001 108.178 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.572 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 19.7 m -162.49 160.33 26.05 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.583 -1.647 . . . . 1.1000000000000001 112.379 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.471 ' CD2' HG23 ' A' ' 65' ' ' VAL . 3.6 m-85 -96.5 114.17 63.92 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.416 -0.914 . . . . 2.1499999999999999 109.218 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HB2' HD21 ' A' ' 94' ' ' ASN . 2.8 Cg_exo -56.01 -68.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.005 1.137 . . . . 0.81000000000000005 111.542 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.8 t -69.75 -156.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.901 -1.12 . . . . 1.8 110.458 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.76 48.82 2.53 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.315 -1.422 . . . . 1.3999999999999999 110.301 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.535 ' OE1' ' CZ ' ' A' ' 21' ' ' PHE . 2.2 mm-40 -85.43 97.5 10.05 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.169 -1.012 . . . . 2.2999999999999998 110.613 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -107.35 111.96 24.56 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.763 -0.775 . . . . 3.0 110.768 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 51' ' ' THR . 1.5 p -67.23 158.23 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.425 -0.91 . . . . 1.1899999999999999 111.261 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' ' N ' ' A' ' 52' ' ' GLN . 30.9 p -133.43 -64.42 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.879 -0.728 . . . . 1.3999999999999999 110.461 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.579 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.8 OUTLIER -88.5 166.2 14.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.073 -1.051 . . . . 2.2000000000000002 109.438 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.06 149.03 2.31 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.344 -1.342 . . . . 1.0900000000000001 112.053 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.417 ' CD1' ' HB2' ' A' ' 55' ' ' SER . 35.0 t-105 -150.6 142.56 23.92 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.58 -0.848 . . . . 0.67000000000000004 110.405 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.3 OUTLIER 64.81 23.26 12.66 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.329 -0.948 . . . . 1.6200000000000001 109.487 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.428 ' HB2' ' CG1' ' A' ' 67' ' ' VAL . 1.7 p -171.84 123.33 0.52 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.278 -0.874 . . . . 1.9199999999999999 110.162 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -86.65 77.96 9.25 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.04 -1.064 . . . . 1.05 109.745 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.9 m -69.53 153.81 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.277 -0.874 . . . . 1.0800000000000001 112.121 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.8 p -154.01 115.69 4.2 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.247 -0.888 . . . . 2.04 110.387 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -92.21 113.27 25.5 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.3 -0.96 . . . . 2.0 110.567 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.9 p -91.24 84.33 5.63 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.42 -0.912 . . . . 0.88 110.943 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.87 -70.63 1.45 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.431 -1.366 . . . . 2.04 110.017 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.85 -19.1 1.03 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.953 -0.699 . . . . 1.96 110.037 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.572 ' CB ' ' OG ' ' A' ' 43' ' ' SER . . . -86.57 -174.36 4.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.206 -0.998 . . . . 1.1000000000000001 110.183 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.627 ' CG1' ' N ' ' A' ' 66' ' ' THR . 44.7 t -145.81 163.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 118.797 -1.161 . . . . 1.1899999999999999 113.311 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.627 ' N ' ' CG1' ' A' ' 65' ' ' VAL . 3.0 m -159.86 146.78 16.35 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.085 -1.416 . . . . 1.22 108.888 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.448 ' N ' HG21 ' A' ' 66' ' ' THR . 3.8 t -139.63 117.28 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.775 -1.17 . . . . 1.05 112.441 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -99.35 92.56 5.48 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.623 -1.171 . . . . 2.6200000000000001 108.487 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.782 ' ND2' ' NE1' ' A' ' 38' ' ' TRP . 12.1 p-10 -73.03 121.27 19.87 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.107 -1.037 . . . . 1.8899999999999999 111.354 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.68 ' N ' HD22 ' A' ' 73' ' ' ASN . . . -45.33 165.34 0.17 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 114.303 -1.317 . . . . 1.0700000000000001 111.608 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -67.69 -38.12 14.72 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 121.96 1.774 . . . . 0.45000000000000001 112.499 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.536 ' CH2' ' OD1' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -69.39 -52.97 21.87 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.048 -1.061 . . . . 0.59999999999999998 111.219 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -78.78 16.59 0.84 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.052 -1.059 . . . . 1.6000000000000001 109.906 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.51 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -144.59 35.68 1.51 Allowed Glycine 0 N--CA 1.485 1.916 0 C-N-CA 119.622 -1.275 . . . . 0.40000000000000002 110.668 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.1 m -104.31 59.39 0.71 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.815 -0.754 . . . . 1.9199999999999999 110.891 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.48 HG13 ' N ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -107.49 135.24 19.74 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.964 -0.694 . . . . 1.1399999999999999 111.636 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 79' ' ' GLY . 5.4 Cg_endo -69.5 150.86 70.32 Favored 'Trans proline' 0 C--O 1.208 -1.022 0 C-N-CA 121.341 1.36 . . . . 0.76000000000000001 110.622 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.585 ' HB3' ' H ' ' A' ' 33' ' ' ALA . . . -37.15 -19.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.36 0.874 . . . . 1.28 113.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 77' ' ' PRO . . . -113.55 67.76 0.25 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.549 -1.42 . . . . 0.66000000000000003 109.549 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.77 -162.79 22.68 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.679 -1.724 . . . . 0.34000000000000002 111.164 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.48 ' N ' HG13 ' A' ' 76' ' ' ILE . 1.4 p -141.11 168.12 20.55 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.687 -0.805 . . . . 1.1000000000000001 112.228 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.16 179.88 5.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.595 -1.261 . . . . 1.04 107.595 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 84' ' ' PHE . 2.7 tt0 -167.41 141.08 3.56 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.1 -1.84 . . . . 2.77 113.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.502 ' CE2' ' CG1' ' A' ' 25' ' ' VAL . 10.1 p90 -153.67 172.56 17.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.755 -1.111 . . . . 2.1600000000000001 109.722 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.12 162.42 30.93 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 117.956 -2.068 . . . . 0.31 112.096 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.616 ' CZ ' ' CB ' ' A' ' 23' ' ' ALA . 2.6 p90 -156.38 174.8 14.89 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.78 -0.768 . . . . 2.1400000000000001 111.14 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -126.93 109.63 12.14 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.71 -0.677 . . . . 1.9199999999999999 110.509 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -118.97 157.84 15.11 Favored Glycine 0 N--CA 1.499 2.893 0 C-N-CA 119.839 -1.172 . . . . 0.57999999999999996 111.446 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.5 p -106.97 151.61 25.07 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 120.228 -0.589 . . . . 1.1499999999999999 110.521 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.774 ' HD1' ' N ' ' A' ' 91' ' ' THR . 2.2 p80 -146.08 -158.38 0.89 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.421 -0.912 . . . . 1.24 111.116 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.774 ' N ' ' HD1' ' A' ' 90' ' ' HIS . 25.0 p -137.11 3.5 2.65 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.559 -0.746 . . . . 2.3399999999999999 110.49 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 81.51 1.6 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.678 -1.249 . . . . 2.9100000000000001 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.736 ' CG2' ' H ' ' A' ' 94' ' ' ASN . 35.8 m -160.86 -145.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.305 -0.958 . . . . 2.1899999999999999 111.041 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.736 ' H ' ' CG2' ' A' ' 93' ' ' THR . 0.0 OUTLIER -100.8 132.15 46.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.785 -0.766 . . . . 2.4199999999999999 111.167 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.47 -105.5 0.37 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.596 -0.729 . . . . 1.6399999999999999 111.247 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.501 ' CB ' ' CE3' ' A' ' 12' ' ' TRP . . . -40.27 107.79 0.48 Allowed Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.721 -0.672 . . . . 1.3100000000000001 111.189 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.498 ' HD2' ' CZ ' ' A' ' 100' ' ' PHE . 2.0 Cg_endo -62.6 -94.95 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 121.05 1.167 . . . . 0.73999999999999999 112.75 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.458 ' H ' ' HB2' ' A' ' 97' ' ' PRO . 7.5 p -151.1 -102.07 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.939 -1.104 . . . . 1.23 112.105 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.4 97.46 11.2 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 118.757 -1.177 . . . . 1.1399999999999999 111.746 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 4.4 m-30 -67.55 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.543 -0.863 . . . . 2.1699999999999999 109.327 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -154.67 109.98 3.1 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.552 -1.659 . . . . 1.1499999999999999 113.145 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.646 ' CD1' ' SG ' ' A' ' 8' ' ' CYS . 3.2 mt -55.93 177.59 0.05 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.919 -0.771 . . . . 1.1000000000000001 108.919 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.67 ' H ' HD21 ' A' ' 103' ' ' ASN . 0.6 OUTLIER -63.99 76.84 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.967 -1.093 . . . . 1.6499999999999999 111.706 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 102' ' ' LEU . . . 109.03 3.86 31.47 Favored Glycine 0 N--CA 1.505 3.26 0 C-N-CA 119.667 -1.254 . . . . 1.27 112.359 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 19.9 p -150.37 152.29 32.83 Favored Pre-proline 0 N--CA 1.493 1.721 0 C-N-CA 118.671 -1.212 . . . . 2.1200000000000001 111.616 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.24 167.09 23.03 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 121.599 1.532 . . . . 0.68999999999999995 111.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.416 ' SG ' ' C ' ' A' ' 8' ' ' CYS . 2.4 t -159.11 104.63 1.7 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.948 -0.701 . . . . 0.45000000000000001 109.874 179.804 -152.118 94.138 -132.79 104.584 2.025 104.407 61.982 53.509 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.31 132.15 45.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.381 0.882 . . . . 1.73 113.381 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.59 165.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.153 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 10' ' ' VAL . . . . . . . . 0 N--CA 1.498 2.788 0 CA-C-O 116.301 -2.388 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.897 0.38 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t -90.55 56.6 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.797 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -161.93 -92.87 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.39 68.32 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.489 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.72 -155.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.866 1.711 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.596 ' H ' ' HB ' ' A' ' 105' ' ' THR . . . -87.03 -161.71 0.71 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.501 -0.879 . . . . 0.74 111.007 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.99 45.65 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.877 -1.689 . . . . 0.42 108.877 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' HD12 ' A' ' 102' ' ' LEU . 15.1 p -58.18 -168.25 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.04 -0.664 . . . . 0.69 110.99 -179.991 53.509 61.982 -132.79 104.407 2.025 104.584 94.138 -152.118 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -152.29 137.76 17.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.927 -1.109 . . . . 1.81 110.624 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 HG13 ' A' ' 27' ' ' VAL . 2.9 m -125.7 127.38 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.544 -0.862 . . . . 0.39 111.249 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.567 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -98.42 164.95 12.07 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.134 -1.027 . . . . 0.29 110.246 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.859 ' CE3' ' HB2' ' A' ' 96' ' ' ALA . 2.2 t-105 -120.54 146.23 46.52 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.954 -0.698 . . . . 0.45 111.989 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.99 72.61 0.47 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.223 -1.951 . . . . 0.32 108.223 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.11 150.65 10.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.573 -0.851 . . . . 0.57 112.589 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -159.15 85.92 0.81 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.722 -1.126 . . . . 1.51 109.151 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.498 ' C ' ' CD ' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -108.21 164.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.648 -0.821 . . . . 2.57 112.712 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -115.99 -83.24 0.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.012 -1.449 . . . . 1.63 110.503 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -94.86 -24.59 16.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.476 -0.89 . . . . 3.18 110.456 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -177.32 -35.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.567 -0.742 . . . . 2.22 109.988 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 19' ' ' THR . . . -71.17 119.56 8.01 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 107.069 -2.412 . . . . 0.84 107.069 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 28.1 p90 -113.74 119.11 36.25 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 119.602 -0.839 . . . . 1.28 112.892 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.571 HG23 ' N ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -71.64 172.47 9.63 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.465 -1.309 . . . . 0.74 107.465 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' CB ' ' CZ ' ' A' ' 86' ' ' PHE . . . -148.97 104.75 3.47 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.181 -1.408 . . . . 0.41 112.176 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.1 102.26 15.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.429 -0.952 . . . . 1.72 108.429 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.706 HG11 ' CE2' ' A' ' 84' ' ' PHE . 16.9 t -101.32 143.56 14.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.567 -0.853 . . . . 0.27 112.545 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.567 ' HB ' HD11 ' A' ' 11' ' ' LEU . 1.3 m -134.05 117.5 16.71 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.987 -1.006 . . . . 0.41 109.135 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.695 HG13 HG12 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -85.25 152.77 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.319 -0.952 . . . . 0.53 112.338 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.74 ' HA ' HG22 ' A' ' 81' ' ' THR . 13.8 tptt -139.51 104.72 5.01 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.85 -1.068 . . . . 2.06 110.088 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.541 ' HB3' HD11 ' A' ' 76' ' ' ILE . 27.7 t-20 -100.72 127.69 47.04 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.538 -0.865 . . . . 1.09 109.73 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.4 t -134.13 10.23 3.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.47 -0.786 . . . . 0.76 110.087 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -59.34 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.526 -0.87 . . . . 1.28 111.003 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 31' ' ' SER . 0.5 OUTLIER 162.61 42.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.051 -0.659 . . . . 0.82 111.181 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.891 ' N ' ' HB2' ' A' ' 78' ' ' ALA . . . -146.61 153.28 46.92 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 118.752 -1.179 . . . . 0.82 111.306 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.05 100.98 0.9 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.519 1.48 . . . . 0.76 110.395 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 35' ' ' VAL . 1.6 t -78.48 98.69 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 118.606 -1.238 . . . . 0.41 111.411 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -107.61 58.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.814 -0.81 . . . . 1.23 108.814 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.63 157.92 26.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.167 -1.973 . . . . 0.28 108.167 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.782 ' NE1' ' ND2' ' A' ' 69' ' ' ASN . 41.3 p-90 -170.56 177.98 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.972 -1.491 . . . . 0.22 112.301 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -141.36 100.08 3.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.052 -0.976 . . . . 0.29 110.641 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.848 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -87.1 173.23 9.39 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.48 -1.288 . . . . 0.24 109.657 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.502 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.4 m -159.52 147.1 17.1 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.996 -1.482 . . . . 0.41 112.404 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD2' ' N ' ' A' ' 43' ' ' SER . 18.8 p90 -174.22 -143.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.961 -1.472 . . . . 1.2 108.178 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.572 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 19.7 m -162.49 160.33 26.05 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.583 -1.647 . . . . 0.51 112.379 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.726 ' CD2' HG21 ' A' ' 65' ' ' VAL . 3.6 m-85 -96.5 114.17 63.92 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.416 -0.914 . . . . 1.23 109.218 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.01 -68.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.005 1.137 . . . . 0.61 111.542 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.8 t -69.75 -156.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.901 -1.12 . . . . 1.52 110.458 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.76 48.82 2.53 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.315 -1.422 . . . . 1.05 110.301 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.535 ' OE1' ' CZ ' ' A' ' 21' ' ' PHE . 2.2 mm-40 -85.43 97.5 10.05 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.169 -1.012 . . . . 1.82 110.613 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.44 ' HB2' HE22 ' A' ' 60' ' ' GLN . 1.5 pp0? -107.35 111.96 24.56 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.763 -0.775 . . . . 2.82 110.768 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 51' ' ' THR . 1.5 p -67.23 158.23 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.425 -0.91 . . . . 0.47 111.261 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' ' N ' ' A' ' 52' ' ' GLN . 30.9 p -133.43 -64.42 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.879 -0.728 . . . . 0.79 110.461 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.579 ' N ' ' OG1' ' A' ' 51' ' ' THR . 4.6 mt-30 -88.5 166.2 14.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.073 -1.051 . . . . 1.7 109.438 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.06 149.03 2.31 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.344 -1.342 . . . . 0.29 112.053 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 55' ' ' SER . 35.0 t-105 -150.6 142.56 23.92 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.58 -0.848 . . . . 0.61 110.405 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.3 OUTLIER 64.81 23.26 12.66 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.329 -0.948 . . . . 1.04 109.487 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.534 ' HG ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 p -171.84 123.33 0.52 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.278 -0.874 . . . . 1.37 110.162 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -86.65 77.96 9.25 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.04 -1.064 . . . . 0.26 109.745 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' C ' HG23 ' A' ' 59' ' ' THR . 16.9 m -69.53 153.81 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.277 -0.874 . . . . 0.39 112.121 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.422 HG23 ' C ' ' A' ' 58' ' ' VAL . 37.8 p -154.01 115.69 4.2 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.247 -0.888 . . . . 1.54 110.387 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.44 HE22 ' HB2' ' A' ' 49' ' ' GLN . 11.8 tt0 -92.21 113.27 25.5 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.3 -0.96 . . . . 2.0 110.567 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 3.9 p -91.24 84.33 5.63 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.42 -0.912 . . . . 0.8 110.943 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.87 -70.63 1.45 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.431 -1.366 . . . . 2.04 110.017 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.85 -19.1 1.03 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.953 -0.699 . . . . 1.45 110.037 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.572 ' CB ' ' OG ' ' A' ' 43' ' ' SER . . . -86.57 -174.36 4.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.206 -0.998 . . . . 0.27 110.183 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.726 HG21 ' CD2' ' A' ' 44' ' ' PHE . 44.7 t -145.81 163.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 118.797 -1.161 . . . . 0.35 113.311 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.627 ' N ' ' CG1' ' A' ' 65' ' ' VAL . 3.0 m -159.86 146.78 16.35 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.085 -1.416 . . . . 0.44 108.888 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 40' ' ' LEU . 3.8 t -139.63 117.28 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.775 -1.17 . . . . 0.63 112.441 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -99.35 92.56 5.48 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.623 -1.171 . . . . 2.07 108.487 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.782 ' ND2' ' NE1' ' A' ' 38' ' ' TRP . 12.1 p-10 -73.03 121.27 19.87 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.107 -1.037 . . . . 1.14 111.354 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.639 ' HB3' ' ND2' ' A' ' 73' ' ' ASN . . . -45.33 165.34 0.17 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 114.303 -1.317 . . . . 0.23 111.608 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 3.7 Cg_endo -67.69 -38.12 14.72 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 121.96 1.774 . . . . 0.4 112.499 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.686 ' CH2' ' ND2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -69.39 -52.97 21.87 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.048 -1.061 . . . . 0.52 111.219 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.686 ' ND2' ' CH2' ' A' ' 72' ' ' TRP . 6.7 p30 -78.78 16.59 0.84 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.052 -1.059 . . . . 1.42 109.906 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.543 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -144.59 35.68 1.51 Allowed Glycine 0 N--CA 1.485 1.916 0 C-N-CA 119.622 -1.275 . . . . 0.4 110.668 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.1 m -104.31 59.39 0.71 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.815 -0.754 . . . . 1.4 110.891 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.566 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -107.49 135.24 19.74 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.964 -0.694 . . . . 0.46 111.636 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 79' ' ' GLY . 5.4 Cg_endo -69.5 150.86 70.32 Favored 'Trans proline' 0 C--O 1.208 -1.022 0 C-N-CA 121.341 1.36 . . . . 0.64 110.622 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.891 ' HB2' ' N ' ' A' ' 33' ' ' ALA . . . -37.15 -19.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.36 0.874 . . . . 0.68 113.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 77' ' ' PRO . . . -113.55 67.76 0.25 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.549 -1.42 . . . . 0.43 109.549 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.77 -162.79 22.68 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.679 -1.724 . . . . 0.31 111.164 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 28' ' ' LYS . 1.4 p -141.11 168.12 20.55 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.687 -0.805 . . . . 0.35 112.228 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.16 179.88 5.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.595 -1.261 . . . . 0.84 107.595 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.454 ' HG2' ' N ' ' A' ' 84' ' ' PHE . 2.7 tt0 -167.41 141.08 3.56 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.1 -1.84 . . . . 2.23 113.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.706 ' CE2' HG11 ' A' ' 25' ' ' VAL . 10.1 p90 -153.67 172.56 17.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.755 -1.111 . . . . 1.24 109.722 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.12 162.42 30.93 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 117.956 -2.068 . . . . 0.28 112.096 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.616 ' CZ ' ' CB ' ' A' ' 23' ' ' ALA . 2.6 p90 -156.38 174.8 14.89 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.78 -0.768 . . . . 1.21 111.14 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -126.93 109.63 12.14 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.71 -0.677 . . . . 1.32 110.509 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -118.97 157.84 15.11 Favored Glycine 0 N--CA 1.499 2.893 0 C-N-CA 119.839 -1.172 . . . . 0.58 111.446 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.5 p -106.97 151.61 25.07 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 120.228 -0.589 . . . . 0.81 110.521 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.536 ' C ' ' ND1' ' A' ' 90' ' ' HIS . 2.2 p80 -146.08 -158.38 0.89 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.421 -0.912 . . . . 1.24 111.116 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.533 ' N ' ' ND1' ' A' ' 90' ' ' HIS . 25.0 p -137.11 3.5 2.65 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.559 -0.746 . . . . 2.02 110.49 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 81.51 1.6 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.678 -1.249 . . . . 2.24 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 1.036 HG22 ' H ' ' A' ' 94' ' ' ASN . 35.8 m -160.86 -145.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.305 -0.958 . . . . 1.73 111.041 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 1.036 ' H ' HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -100.8 132.15 46.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.785 -0.766 . . . . 2.16 111.167 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.47 -105.5 0.37 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.596 -0.729 . . . . 1.21 111.247 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.859 ' HB2' ' CE3' ' A' ' 12' ' ' TRP . . . -40.27 107.79 0.48 Allowed Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.721 -0.672 . . . . 0.69 111.189 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 100' ' ' PHE . 2.0 Cg_endo -62.6 -94.95 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 121.05 1.167 . . . . 0.74 112.75 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.868 ' O ' HG13 ' A' ' 109' ' ' VAL . 7.5 p -151.1 -102.07 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.939 -1.104 . . . . 0.8 112.105 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.4 97.46 11.2 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 118.757 -1.177 . . . . 0.41 111.746 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 4.4 m-30 -67.55 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.543 -0.863 . . . . 1.28 109.327 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -154.67 109.98 3.1 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.552 -1.659 . . . . 0.65 113.145 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.682 HD12 ' SG ' ' A' ' 8' ' ' CYS . 3.2 mt -55.93 177.59 0.05 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.919 -0.771 . . . . 0.4 108.919 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.563 ' HB3' ' H ' ' A' ' 39' ' ' THR . 14.5 p-10 -63.99 76.84 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.967 -1.093 . . . . 1.65 111.706 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 102' ' ' LEU . . . 109.03 3.86 31.47 Favored Glycine 0 N--CA 1.505 3.26 0 C-N-CA 119.667 -1.254 . . . . 0.7 112.359 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 19.9 p -150.37 152.29 32.83 Favored Pre-proline 0 N--CA 1.493 1.721 0 C-N-CA 118.671 -1.212 . . . . 1.47 111.616 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.24 167.09 23.03 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 121.599 1.532 . . . . 0.6 111.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.416 ' SG ' ' C ' ' A' ' 8' ' ' CYS . 2.4 t -159.11 104.63 1.7 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.948 -0.701 . . . . 0.44 109.874 179.804 -152.118 94.138 -132.79 104.584 2.025 104.407 61.982 53.509 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.31 132.15 45.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.381 0.882 . . . . 1.04 113.381 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.868 HG13 ' O ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -48.59 165.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.153 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 10' ' ' VAL . . . . . . . . 0 N--CA 1.498 2.788 0 CA-C-O 116.301 -2.388 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.897 0.38 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 t -90.55 56.6 3.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.797 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -161.93 -92.87 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.877 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.39 68.32 0.03 OUTLIER Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.489 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.72 -155.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 121.866 1.711 . . . . 0.0 111.293 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.596 ' H ' ' HB ' ' A' ' 105' ' ' THR . . . -87.03 -161.71 0.71 Allowed 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.501 -0.879 . . . . 0.74 111.007 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.99 45.65 0.12 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.877 -1.689 . . . . 0.42 108.877 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' HD12 ' A' ' 102' ' ' LEU . 15.1 p -58.18 -168.25 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.04 -0.664 . . . . 0.69 110.99 -179.991 53.509 61.982 -132.79 104.407 2.025 104.584 94.138 -152.118 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' N ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -152.29 137.76 17.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 118.927 -1.109 . . . . 1.81 110.624 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.695 HG12 HG13 ' A' ' 27' ' ' VAL . 2.9 m -125.7 127.38 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.544 -0.862 . . . . 0.39 111.249 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.567 HD11 ' HB ' ' A' ' 26' ' ' THR . 0.1 OUTLIER -98.42 164.95 12.07 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.134 -1.027 . . . . 0.29 110.246 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.859 ' CE3' ' HB2' ' A' ' 96' ' ' ALA . 2.2 t-105 -120.54 146.23 46.52 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.954 -0.698 . . . . 0.45 111.989 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.99 72.61 0.47 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.223 -1.951 . . . . 0.32 108.223 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.11 150.65 10.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 C-N-CA 119.573 -0.851 . . . . 0.57 112.589 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -159.15 85.92 0.81 Allowed 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.722 -1.126 . . . . 1.51 109.151 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.878 HE21 ' H ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -108.21 164.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.648 -0.821 . . . . 2.57 112.712 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.449 ' CD2' ' N ' ' A' ' 17' ' ' TRP . 0.8 OUTLIER -115.99 -83.24 0.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.012 -1.449 . . . . 1.63 110.503 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.86 -24.59 16.96 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.476 -0.89 . . . . 3.18 110.456 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -177.32 -35.29 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.567 -0.742 . . . . 2.22 109.988 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 19' ' ' THR . . . -71.17 119.56 8.01 Favored Glycine 0 N--CA 1.477 1.381 0 N-CA-C 107.069 -2.412 . . . . 0.84 107.069 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 28.1 p90 -113.74 119.11 36.25 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 119.602 -0.839 . . . . 1.28 112.892 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.571 HG23 ' N ' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -71.64 172.47 9.63 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.465 -1.309 . . . . 0.74 107.465 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' CB ' ' CZ ' ' A' ' 86' ' ' PHE . . . -148.97 104.75 3.47 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.181 -1.408 . . . . 0.41 112.176 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -91.1 102.26 15.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.429 -0.952 . . . . 1.72 108.429 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.706 HG11 ' CE2' ' A' ' 84' ' ' PHE . 16.9 t -101.32 143.56 14.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.567 -0.853 . . . . 0.27 112.545 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.567 ' HB ' HD11 ' A' ' 11' ' ' LEU . 1.3 m -134.05 117.5 16.71 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.987 -1.006 . . . . 0.41 109.135 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.695 HG13 HG12 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -85.25 152.77 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.319 -0.952 . . . . 0.53 112.338 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.74 ' HA ' HG22 ' A' ' 81' ' ' THR . 13.8 tptt -139.51 104.72 5.01 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.85 -1.068 . . . . 2.06 110.088 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.703 HD22 ' C ' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -100.72 127.69 47.04 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.538 -0.865 . . . . 1.09 109.73 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.446 ' N ' HD22 ' A' ' 29' ' ' ASN . 2.4 t -134.13 10.23 3.84 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.47 -0.786 . . . . 0.76 110.087 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -59.34 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.526 -0.87 . . . . 1.28 111.003 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 31' ' ' SER . 0.5 OUTLIER 162.61 42.71 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 120.051 -0.659 . . . . 0.82 111.181 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.891 ' N ' ' HB2' ' A' ' 78' ' ' ALA . . . -146.61 153.28 46.92 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 118.752 -1.179 . . . . 0.82 111.306 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -70.05 100.98 0.9 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.519 1.48 . . . . 0.76 110.395 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 35' ' ' VAL . 1.6 t -78.48 98.69 2.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 118.606 -1.238 . . . . 0.41 111.411 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -107.61 58.82 0.62 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.814 -0.81 . . . . 1.23 108.814 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.63 157.92 26.72 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.167 -1.973 . . . . 0.28 108.167 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.782 ' NE1' ' ND2' ' A' ' 69' ' ' ASN . 41.3 p-90 -170.56 177.98 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.972 -1.491 . . . . 0.22 112.301 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.563 ' H ' ' HB3' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -141.36 100.08 3.71 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.052 -0.976 . . . . 0.29 110.641 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.848 ' O ' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -87.1 173.23 9.39 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.48 -1.288 . . . . 0.24 109.657 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.502 ' N ' ' HG ' ' A' ' 40' ' ' LEU . 1.4 m -159.52 147.1 17.1 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 117.996 -1.482 . . . . 0.41 112.404 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' CD2' ' N ' ' A' ' 43' ' ' SER . 18.8 p90 -174.22 -143.12 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.961 -1.472 . . . . 1.2 108.178 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.572 ' OG ' ' CB ' ' A' ' 64' ' ' ALA . 19.7 m -162.49 160.33 26.05 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 117.583 -1.647 . . . . 0.51 112.379 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.726 ' CD2' HG21 ' A' ' 65' ' ' VAL . 3.6 m-85 -96.5 114.17 63.92 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.416 -0.914 . . . . 1.23 109.218 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HB2' HD22 ' A' ' 94' ' ' ASN . 2.8 Cg_exo -56.01 -68.2 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.005 1.137 . . . . 0.61 111.542 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.8 t -69.75 -156.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.901 -1.12 . . . . 1.52 110.458 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.76 48.82 2.53 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.315 -1.422 . . . . 1.05 110.301 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.535 ' OE1' ' CZ ' ' A' ' 21' ' ' PHE . 2.2 mm-40 -85.43 97.5 10.05 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.169 -1.012 . . . . 1.82 110.613 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.543 HE22 HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -107.35 111.96 24.56 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.763 -0.775 . . . . 2.82 110.768 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 51' ' ' THR . 1.5 p -67.23 158.23 5.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.425 -0.91 . . . . 0.47 111.261 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.579 ' OG1' ' N ' ' A' ' 52' ' ' GLN . 30.9 p -133.43 -64.42 0.72 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.879 -0.728 . . . . 0.79 110.461 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.579 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.8 OUTLIER -88.5 166.2 14.35 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.073 -1.051 . . . . 1.7 109.438 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.06 149.03 2.31 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.344 -1.342 . . . . 0.29 112.053 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 55' ' ' SER . 35.0 t-105 -150.6 142.56 23.92 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.58 -0.848 . . . . 0.61 110.405 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 54' ' ' TRP . 0.3 OUTLIER 64.81 23.26 12.66 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.329 -0.948 . . . . 1.04 109.487 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.534 ' HG ' ' HD1' ' A' ' 84' ' ' PHE . 1.7 p -171.84 123.33 0.52 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.278 -0.874 . . . . 1.37 110.162 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -86.65 77.96 9.25 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.04 -1.064 . . . . 0.26 109.745 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' C ' HG23 ' A' ' 59' ' ' THR . 16.9 m -69.53 153.81 8.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.277 -0.874 . . . . 0.39 112.121 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.422 HG23 ' C ' ' A' ' 58' ' ' VAL . 37.8 p -154.01 115.69 4.2 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.247 -0.888 . . . . 1.54 110.387 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.44 HE22 ' HB2' ' A' ' 49' ' ' GLN . 11.8 tt0 -92.21 113.27 25.5 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.3 -0.96 . . . . 2.0 110.567 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 64' ' ' ALA . 3.9 p -91.24 84.33 5.63 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.42 -0.912 . . . . 0.8 110.943 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.87 -70.63 1.45 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.431 -1.366 . . . . 2.04 110.017 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.85 -19.1 1.03 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.953 -0.699 . . . . 1.45 110.037 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.572 ' CB ' ' OG ' ' A' ' 43' ' ' SER . . . -86.57 -174.36 4.96 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.206 -0.998 . . . . 0.27 110.183 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.726 HG21 ' CD2' ' A' ' 44' ' ' PHE . 44.7 t -145.81 163.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 118.797 -1.161 . . . . 0.35 113.311 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.627 ' N ' ' CG1' ' A' ' 65' ' ' VAL . 3.0 m -159.86 146.78 16.35 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.085 -1.416 . . . . 0.44 108.888 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 40' ' ' LEU . 3.8 t -139.63 117.28 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 118.775 -1.17 . . . . 0.63 112.441 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -99.35 92.56 5.48 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.623 -1.171 . . . . 2.07 108.487 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.782 ' ND2' ' NE1' ' A' ' 38' ' ' TRP . 12.1 p-10 -73.03 121.27 19.87 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.107 -1.037 . . . . 1.14 111.354 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.715 ' N ' HD21 ' A' ' 73' ' ' ASN . . . -45.33 165.34 0.17 Allowed Pre-proline 0 C--N 1.304 -1.407 0 CA-C-N 114.303 -1.317 . . . . 0.23 111.608 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.618 ' HD2' ' HB1' ' A' ' 70' ' ' ALA . 3.7 Cg_endo -67.69 -38.12 14.72 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 121.96 1.774 . . . . 0.4 112.499 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.622 ' NE1' ' HB1' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -69.39 -52.97 21.87 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.048 -1.061 . . . . 0.52 111.219 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.715 HD21 ' N ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -78.78 16.59 0.84 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.052 -1.059 . . . . 1.42 109.906 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.543 ' HA3' ' ND2' ' A' ' 69' ' ' ASN . . . -144.59 35.68 1.51 Allowed Glycine 0 N--CA 1.485 1.916 0 C-N-CA 119.622 -1.275 . . . . 0.4 110.668 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.1 m -104.31 59.39 0.71 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 119.815 -0.754 . . . . 1.4 110.891 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.566 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -107.49 135.24 19.74 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 119.964 -0.694 . . . . 0.46 111.636 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.606 ' O ' ' N ' ' A' ' 79' ' ' GLY . 5.4 Cg_endo -69.5 150.86 70.32 Favored 'Trans proline' 0 C--O 1.208 -1.022 0 C-N-CA 121.341 1.36 . . . . 0.64 110.622 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.891 ' HB2' ' N ' ' A' ' 33' ' ' ALA . . . -37.15 -19.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 113.36 0.874 . . . . 0.68 113.36 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 77' ' ' PRO . . . -113.55 67.76 0.25 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.549 -1.42 . . . . 0.43 109.549 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.77 -162.79 22.68 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.679 -1.724 . . . . 0.31 111.164 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.74 HG22 ' HA ' ' A' ' 28' ' ' LYS . 1.4 p -141.11 168.12 20.55 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.687 -0.805 . . . . 0.35 112.228 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.16 179.88 5.74 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.595 -1.261 . . . . 0.84 107.595 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.454 ' HG2' ' N ' ' A' ' 84' ' ' PHE . 2.7 tt0 -167.41 141.08 3.56 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 117.1 -1.84 . . . . 2.23 113.192 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.706 ' CE2' HG11 ' A' ' 25' ' ' VAL . 10.1 p90 -153.67 172.56 17.06 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.755 -1.111 . . . . 1.24 109.722 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.12 162.42 30.93 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 117.956 -2.068 . . . . 0.28 112.096 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.616 ' CZ ' ' CB ' ' A' ' 23' ' ' ALA . 2.6 p90 -156.38 174.8 14.89 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.78 -0.768 . . . . 1.21 111.14 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -126.93 109.63 12.14 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.71 -0.677 . . . . 1.32 110.509 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 21' ' ' PHE . . . -118.97 157.84 15.11 Favored Glycine 0 N--CA 1.499 2.893 0 C-N-CA 119.839 -1.172 . . . . 0.58 111.446 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 97.5 p -106.97 151.61 25.07 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 120.228 -0.589 . . . . 0.81 110.521 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.536 ' C ' ' ND1' ' A' ' 90' ' ' HIS . 2.2 p80 -146.08 -158.38 0.89 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.421 -0.912 . . . . 1.24 111.116 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.533 ' N ' ' ND1' ' A' ' 90' ' ' HIS . 25.0 p -137.11 3.5 2.65 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 115.559 -0.746 . . . . 2.02 110.49 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 81.51 1.6 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.678 -1.249 . . . . 2.24 110.406 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 1.036 HG22 ' H ' ' A' ' 94' ' ' ASN . 35.8 m -160.86 -145.24 0.11 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.305 -0.958 . . . . 1.73 111.041 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 1.036 ' H ' HG22 ' A' ' 93' ' ' THR . 0.0 OUTLIER -100.8 132.15 46.34 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.785 -0.766 . . . . 2.16 111.167 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.47 -105.5 0.37 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.596 -0.729 . . . . 1.21 111.247 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.859 ' HB2' ' CE3' ' A' ' 12' ' ' TRP . . . -40.27 107.79 0.48 Allowed Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.721 -0.672 . . . . 0.69 111.189 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 100' ' ' PHE . 2.0 Cg_endo -62.6 -94.95 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 121.05 1.167 . . . . 0.74 112.75 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.868 ' O ' HG13 ' A' ' 109' ' ' VAL . 7.5 p -151.1 -102.07 0.06 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.939 -1.104 . . . . 0.8 112.105 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -90.4 97.46 11.2 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 118.757 -1.177 . . . . 0.41 111.746 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 100' ' ' PHE . 4.4 m-30 -67.55 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.543 -0.863 . . . . 1.28 109.327 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.8 m -154.67 109.98 3.1 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.552 -1.659 . . . . 0.65 113.145 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.682 HD12 ' SG ' ' A' ' 8' ' ' CYS . 3.2 mt -55.93 177.59 0.05 Allowed 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.919 -0.771 . . . . 0.4 108.919 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.769 HD22 ' H ' ' A' ' 103' ' ' ASN . 0.6 OUTLIER -63.99 76.84 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.967 -1.093 . . . . 1.65 111.706 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 102' ' ' LEU . . . 109.03 3.86 31.47 Favored Glycine 0 N--CA 1.505 3.26 0 C-N-CA 119.667 -1.254 . . . . 0.7 112.359 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.599 ' O ' ' N ' ' A' ' 102' ' ' LEU . 19.9 p -150.37 152.29 32.83 Favored Pre-proline 0 N--CA 1.493 1.721 0 C-N-CA 118.671 -1.212 . . . . 1.47 111.616 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -68.24 167.09 23.03 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 121.599 1.532 . . . . 0.6 111.781 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.416 ' SG ' ' C ' ' A' ' 8' ' ' CYS . 2.4 t -159.11 104.63 1.7 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.948 -0.701 . . . . 0.44 109.874 179.804 -152.118 94.138 -132.79 104.584 2.025 104.407 61.982 53.509 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.31 132.15 45.98 Favored 'General case' 0 N--CA 1.509 2.496 0 N-CA-C 113.381 0.882 . . . . 1.04 113.381 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.868 HG13 ' O ' ' A' ' 98' ' ' THR . 0.0 OUTLIER -48.59 165.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.552 -1.259 . . . . 0.0 110.153 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 10' ' ' VAL . . . . . . . . 0 N--CA 1.498 2.788 0 CA-C-O 116.301 -2.388 . . . . 0.0 110.362 -179.996 . . . . . . . . 1 1 . 1 stop_ save_